ATE168131T1 - T-cadherin-bindungsmolekül - Google Patents

T-cadherin-bindungsmolekül

Info

Publication number
ATE168131T1
ATE168131T1 AT92900808T AT92900808T ATE168131T1 AT E168131 T1 ATE168131 T1 AT E168131T1 AT 92900808 T AT92900808 T AT 92900808T AT 92900808 T AT92900808 T AT 92900808T AT E168131 T1 ATE168131 T1 AT E168131T1
Authority
AT
Austria
Prior art keywords
cadherin
binding molecule
various forms
polypeptides
detecting
Prior art date
Application number
AT92900808T
Other languages
English (en)
Inventor
Barbara Ranscht
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of ATE168131T1 publication Critical patent/ATE168131T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92900808T 1990-10-30 1991-10-30 T-cadherin-bindungsmolekül ATE168131T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60729390A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
ATE168131T1 true ATE168131T1 (de) 1998-07-15

Family

ID=24431648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900808T ATE168131T1 (de) 1990-10-30 1991-10-30 T-cadherin-bindungsmolekül

Country Status (8)

Country Link
US (4) US5585351A (de)
EP (1) EP0619841B1 (de)
JP (1) JPH06505962A (de)
AT (1) ATE168131T1 (de)
AU (1) AU669474B2 (de)
CA (1) CA2095115A1 (de)
DE (1) DE69129760T2 (de)
WO (1) WO1992008731A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008731A2 (en) * 1990-10-30 1992-05-29 La Jolla Cancer Research Foundation T-cadherin adhesion molecule
US5646250A (en) * 1992-04-17 1997-07-08 Doheny Eye Institute Cadherin polypeptides
US5597725A (en) * 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
EP2325203A2 (de) 1992-04-17 2011-05-25 Doheny Eye Institute Materialien und Methoden zur Herstellung von Cadherinen
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US6346512B1 (en) 1996-07-12 2002-02-12 Mcgill University Compounds and methods for modulating cell adhesion
US6465427B1 (en) 1996-07-12 2002-10-15 Mcgill University Compounds and methods for modulating cell adhesion
US6207639B1 (en) 1996-07-12 2001-03-27 Mcgill University Compounds and methods for modulating neurite outgrowth
US6417325B1 (en) 1996-07-12 2002-07-09 Mcgill University Compounds and methods for cancer therapy
US6562786B1 (en) 1996-07-12 2003-05-13 Mcgill University Compounds and methods for modulating apoptosis
EP0937103B1 (de) 1996-07-12 2007-11-28 McGILL UNIVERSITY Verbindungen und verfahren zur regulierung der zellanlagerung
US7122623B2 (en) 1996-07-12 2006-10-17 Adherex Technologies, Inc. Compounds and methods for modulating cell adhesion
US6610821B1 (en) 1996-07-12 2003-08-26 Mcgill University Compounds and methods for modulating endothelial cell adhesion
US6169071B1 (en) 1996-07-12 2001-01-02 Mcgill University Compounds and methods for modulating cell adhesion
US20040006011A1 (en) * 1996-07-12 2004-01-08 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US6333307B1 (en) 1996-07-12 2001-12-25 Mcgill University Compounds and method for modulating neurite outgrowth
US6203788B1 (en) * 1997-09-29 2001-03-20 Adherex Inc. Compounds and methods for regulating cell adhesion
US6638911B1 (en) 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
US20050203025A1 (en) * 1998-05-05 2005-09-15 Adherex Technologies, Inc. Compounds and methods for modulating nonclassical cadherin-mediated functions
US6472367B1 (en) 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
US7481999B2 (en) * 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
WO2001062206A2 (en) * 2000-02-22 2001-08-30 Mount Sinai School Of Medicine Of New York University N-cadherin modulated migration, invasion, and metastasis
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
CA2506037A1 (en) * 2002-11-14 2004-06-10 Adherex Technologies, Inc. Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
EP1627229A2 (de) * 2003-04-29 2006-02-22 Cytos Biotechnology AG Verfahren und zusammensetzungen zur modulation der wechselwirkung zwischen adiponectin und dessen rezeptor
WO2006045849A1 (en) * 2004-10-29 2006-05-04 Cytos Biotechnology Ag T-cadherin antigen arrays and uses thereof
KR100990027B1 (ko) * 2005-04-26 2010-10-26 화이자 인코포레이티드 Ｐ-카드헤린 항체
US20060292159A1 (en) * 2005-06-08 2006-12-28 Ranscht Barbara E Methods for the inhibition of neovascularization and cancer metastasis
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008731A2 (en) * 1990-10-30 1992-05-29 La Jolla Cancer Research Foundation T-cadherin adhesion molecule

Also Published As

Publication number Publication date
EP0619841A1 (de) 1994-10-19
DE69129760D1 (de) 1998-08-13
US5863804A (en) 1999-01-26
WO1992008731A2 (en) 1992-05-29
DE69129760T2 (de) 1999-03-25
AU669474B2 (en) 1996-06-13
US5585351A (en) 1996-12-17
US5837525A (en) 1998-11-17
AU8953191A (en) 1992-06-11
US5811518A (en) 1998-09-22
EP0619841B1 (de) 1998-07-08
EP0619841A4 (de) 1994-05-17
WO1992008731A3 (en) 1992-06-25
CA2095115A1 (en) 1992-05-01
JPH06505962A (ja) 1994-07-07

Similar Documents

Publication Publication Date Title
DE69129760D1 (de) T-cadherin-bindungsmolekül
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
DE60030769D1 (de) Verfahren zur behandlung von entzündungen
DE69433371D1 (de) Polypeptid, fähig zur Inhibierung der Bindung zwischen menschliches IL-6 und dessen Rezeptor
ATE159429T1 (de) Methode zum überbringen von agenzien an zielzellen
NO963785L (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
FI941572A0 (fi) Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
DK0784683T3 (da) TIE-2-ligander, fremgangsmåder til dannelse af disse og anvendelser deraf
DE68925226D1 (de) Monoklonale Antikörper
FI92603B (fi) Mikrobinen menetelmä syklosporiinien valmistamiseksi
EP0215625A3 (en) Protein recovery
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
EP0222998A3 (en) Monoclonal antibodies and methods for fungal patthogen detection
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
FI883526A7 (fi) Parkitusapuaine, sen käyttö ja menetelmä nahan parkitsemiseksi
FI964997A7 (fi) Menetelmä tuumorisolun kasvun estämiseksi käyttäen syndekaani-1:n solu n ulkoista osaa
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
DE68914645D1 (de) Verfahren zur mikrobiologischen reinigung von wasser.
ATE288280T1 (de) Verfahren zum blokieren von sec-rezeptoren
DE3583265D1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
EP0369816A3 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
FR2693209B1 (fr) Procédé de détermination de la taille en nucléotides de fragments d'ADN.
FR2679235B1 (fr) Methode de purification des aminoacides, des acides nucleiques et de leurs derives.
ATE309371T1 (de) Protein mit dnase-aktivität
NZ333075A (en) isolated protein markers for use in diagnosing esophageal cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties